---
figid: PMC5219787__13045_2016_373_Fig5_HTML
figtitle: PI3K-AKT-mTOR and RAS-RAF-MEK-ERK pathways
organisms:
- NA
pmcid: PMC5219787
filename: 13045_2016_373_Fig5_HTML.jpg
figlink: /pmc/articles/PMC5219787/figure/Fig5/
number: F5
caption: PI3K-AKT-mTOR and RAS-RAF-MEK-ERK pathways. Growth factor binds to epidermal
  growth factor receptor and can proceed by two different pathways. For the PI3 pathway,
  the ligand activates tyrosine kinase receptor activity resulting in phosphorylation
  of receptor. PI3K binds to phosphorylated receptor and becomes activated. PI3K then
  binds to PIP2 on inner membrane and phosphorylates PIP2 to PIP3. PIP3 activates
  AKT via PDK1. AKT can then phosphorylate and activate protein mTOR which results
  in cell growth, cell proliferation, and cell survival. For the RAS-RAF pathway,
  growth factor binding to tyrosine kinase receptor activates RAS which in turn activates
  RAF. RAF activates MEK which phosphorylates ERK to decrease apoptosis and increase
  cell proliferation and growth. The compound sulforaphane suppresses the phosphorylation
  of AKT and ERK
papertitle: 'Natural compounds targeting major cell signaling pathways: a novel paradigm
  for osteosarcoma therapy.'
reftext: Pablo Angulo, et al. J Hematol Oncol. 2017;10:10.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8952538
figid_alias: PMC5219787__F5
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC5219787__F5
ndex: dec91004-df14-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5219787__13045_2016_373_Fig5_HTML.html
  '@type': Dataset
  description: PI3K-AKT-mTOR and RAS-RAF-MEK-ERK pathways. Growth factor binds to
    epidermal growth factor receptor and can proceed by two different pathways. For
    the PI3 pathway, the ligand activates tyrosine kinase receptor activity resulting
    in phosphorylation of receptor. PI3K binds to phosphorylated receptor and becomes
    activated. PI3K then binds to PIP2 on inner membrane and phosphorylates PIP2 to
    PIP3. PIP3 activates AKT via PDK1. AKT can then phosphorylate and activate protein
    mTOR which results in cell growth, cell proliferation, and cell survival. For
    the RAS-RAF pathway, growth factor binding to tyrosine kinase receptor activates
    RAS which in turn activates RAF. RAF activates MEK which phosphorylates ERK to
    decrease apoptosis and increase cell proliferation and growth. The compound sulforaphane
    suppresses the phosphorylation of AKT and ERK
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Ras64B
  - Ras85D
  - Pten
  - Pdk1
  - Raf
  - Akt
  - Dsor1
  - Mtk
  - gig
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Tsc1
  - CycE
  - cyc
  - Erk7
  - rl
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - KRAS
  - HRAS
  - NRAS
  - PTEN
  - PDK1
  - PDPK1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - TSC2
  - TSC1
  - CCL26
  - EPHB2
  - MAPK1
  - MAPK3
  - Sulforaphane
  - Tyrosine
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
